Controlling gene expression in cells using light and magnetic fields
Official title: Semi-synthetic, magneto-photonic circuit for non-invasive control of cellular function
Funded at Central Michigan University · NIH-10277517 · Data updated 2026-11-12
This study is working on a new way to control how genes work in cells using light and electromagnetic fields, which could help improve treatments for different diseases by allowing doctors to target specific genes without disrupting the cell's normal functions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Central Michigan University NIH-funded |
| Lab location | 1 site (Mount Pleasant, United States) |
| Project start | September 22, 2021 |
| Project end | September 21, 2025 |
| Funding year | 2021 |
| Award (this year) | $2,026,634 |
| NIH project number | 1R01EB031936-01 |
| Project ID | NIH-10277517 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research would include individuals with conditions that could benefit from targeted gene therapies or those involved in studies of cellular function.
✕Less likely to help
Patients with conditions that do not involve cellular dysfunction or gene expression issues may not benefit from this research.
What this research studies
This research focuses on developing a new tool that allows for precise control of gene expression within cells using electromagnetic fields and light. By creating a synthetic biological system, researchers aim to manipulate cellular functions remotely, which could lead to advancements in therapeutic applications. The approach involves designing biomagnetic switches that convert electromagnetic energy into biological actions, enabling targeted gene activation without interfering with existing cellular processes. This innovative method could revolutionize how we understand and treat various diseases at the cellular level.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that allow for precise control of cellular functions, improving treatment options for various diseases.
How similar studies have gone: While the approach of using electromagnetic fields for gene control is innovative, similar techniques in synthetic biology have shown promise in other contexts, suggesting potential for success.
Where this research is happening
-
Central Michigan University
Mount Pleasant, United States Active
Researchers
- Principal investigator: Hochgeschwender, Ute H — Central Michigan University
- Study coordinator: Hochgeschwender, Ute H
Related research
Other NIH-funded projects on the same topics.
-
Personalized immune care for critically ill children with sepsis
A multi-center effort uses rapid immune-phenotype tests to tailor treatments for children with sepsis-related organ failure.
-
Copines and calcium balance in cells
A researcher team is studying how copine proteins help cells manage calcium, using a model organism to better understand what this could mean for human health.
-
BiViSTA: a glow-in-the-dark virus sensor that helps kill brain tumors
A patient-friendly project to make glioblastoma therapy safer and more effective by using a bioluminescent viral sensor to trigger targeted tumor cell death.
-
Bioluminescent FAK Sensor and Gene Screen to Map Cell Adhesion
A research team is creating a glowing FAK sensor and scanning the genome to find genes that control how cells stick together and move, which could inform breast cancer biology.
-
GATAD2 and NuRD’s role in FOXO/daf-16 control of stem cell fate
This grant studies how a key human-like stem-cell regulator interacts with chromatin factors to keep stem cells multipotent, using a worm model to illuminate potential human biology.
-
Using Machine Learning to Find Factors Linked to Disordered Eating Risk and Treatment in Rural Teens
A machine learning study with rural teens aims to identify the most important factors that influence disordered eating risk and how treatments work, with the goal of informing better care for this age group.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.